Summary of Classification and Labelling
Notified classification and labelling
General Information
EC / List no.
|
Name |
CAS Number
|
---|---|---|
806-589-8 | 3-Pyridinecarboxamide, N-(3-fluoro-4-((1-methyl6-(1H-pyrazol-4-yl)-1H-indazol-5-yl)oxy)phenyl)-1-(4-flurophenyl)-1,2-dihydro-6-methyl-2-oxo-*N-(3-Fluoro-4-((1-methyl-6-(1H-pyrazol-4-yl)-1H-indazol-5-yl)oxy)phenyl)-1-(4-fluorophenyl)-6-methyl-2-oxo-1,2-dihydropyridine-3-carboxamide | 1206799-15-6 |
Notified classification and labelling according to CLP criteria
Classification | Labelling | Specific Concentration limits, M-Factors | Notes | Classification affected by Impurities / Additives
|
Additional Notified Information
|
Number of Notifiers
|
Joint Entries
|
||||
---|---|---|---|---|---|---|---|---|---|---|---|
Hazard Class and Category Code(s) | Hazard Statement Code(s) | Hazard Statement Code(s) | Supplementary Hazard Statement Code(s) | Pictograms, Signal Word Code(s) | |||||||
Acute Tox. 4 | H302 | H302 |
GHS07 GHS08 Dgr |
State/Form
|
1 | View details | |||||
H351 | |||||||||||
Repr. 1B | H360 | H360 | |||||||||
STOT RE 1 | H372 (Kidney, bone ma...) | H372 | |||||||||
Repr. 1B | H360 | H360 |
GHS08 Dgr |
State/Form
|
1 | View details | |||||
STOT RE 1 | H372 (General STOT) | H372 | |||||||||
Acute Tox. 4 | H302 | H302 |
GHS07 GHS08 Dgr |
State/Form
|
1 | View details | |||||
Repr. 1A | H360 | H360 | |||||||||
STOT RE 1 | H372 (not specified) | H372 |
Number of Aggregated Notifications: 3